---
figid: PMC4217731__pone.0110446.g007
figlink: /pmc/articles/PMC4217731/figure/pone-0110446-g007/
number: F7
caption: Rho-kinase inhibition activates AMPKα2 via LKB1 pathway with a resultant
  increase in energy consumption and improvement of metabolic disorders (e.g. hypertension,
  obesity and hyperlipidemia). Although Rho-kinase inhibition also improves insulin
  tolerance, this might not be mediated by AMPK activation, at least in the present
  study.
pmcid: PMC4217731
papertitle: Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation
  of AMPK Pathway in Mice.
reftext: Kazuki Noda, et al. PLoS One. 2014;9(11):e110446.
pmc_ranked_result_index: '24751'
pathway_score: 0.9326154
filename: pone.0110446.g007.jpg
figtitle: Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation
  of AMPK Pathway in Mice
year: '2014'
organisms:
- Homo sapiens
ndex: 16f9ad0a-dee5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4217731__pone.0110446.g007.html
  '@type': Dataset
  description: Rho-kinase inhibition activates AMPKα2 via LKB1 pathway with a resultant
    increase in energy consumption and improvement of metabolic disorders (e.g. hypertension,
    obesity and hyperlipidemia). Although Rho-kinase inhibition also improves insulin
    tolerance, this might not be mediated by AMPK activation, at least in the present
    study.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX4I1
  - CPT1A
  - PRKAG1
  - PRKAA2
  - PRKAB1
  - CPT1B
  - G6PC
  - PRKAG2
  - PPARGC1A
  - PRKAB2
  - PRKAG3
  - PRKAA1
  - STK11
  - PPARA
  - Fasudil
  - Y27632
  - fatty acid
genes:
- word: (Cox4i1)
  symbol: COX4I1
  source: hgnc_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: Cpt1a)
  symbol: CPT1A
  source: hgnc_symbol
  hgnc_symbol: CPT1A
  entrez: '1374'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: Cpt1b)
  symbol: CPT1B
  source: hgnc_symbol
  hgnc_symbol: CPT1B
  entrez: '1375'
- word: (G6pc)
  symbol: G6PC
  source: hgnc_symbol
  hgnc_symbol: G6PC
  entrez: '2538'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: (Ppargc1a)
  symbol: PPARGC1A
  source: hgnc_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: (Ppara,
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
chemicals:
- word: Fasudil
  source: MESH
  identifier: C049347
- word: Y27632
  source: MESH
  identifier: C108830
- word: fatty acid
  source: MESH
  identifier: D005227
diseases: []
figid_alias: PMC4217731__F7
redirect_from: /figures/PMC4217731__F7
figtype: Figure
---
